Los Angeles Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41M | Sell |
65,157
-76,900
| -54% | -$1.66M | 0.01% | 548 |
|
|
2025
Q1 | $2.36M | Buy |
142,057
+27,522
| +24% | +$457K | 0.01% | 375 |
|
|
2024
Q4 | $2.1M | Buy |
114,535
+70,238
| +159% | +$1.29M | 0.01% | 441 |
|
|
2024
Q3 | $681K | Sell |
44,297
-6,672
| -13% | -$103K | ﹤0.01% | 776 |
|
|
2024
Q2 | $828K | Sell |
50,969
-16,505
| -24% | -$268K | ﹤0.01% | 719 |
|
|
2024
Q1 | $1.25M | Buy |
67,474
+2,295
| +4% | +$42.4K | ﹤0.01% | 622 |
|
|
2023
Q4 | $2.04M | Buy |
65,179
+19,871
| +44% | +$622K | 0.01% | 479 |
|
|
2023
Q3 | $944K | Buy |
45,308
+3,771
| +9% | +$78.6K | ﹤0.01% | 660 |
|
|
2023
Q2 | $995K | Buy |
41,537
+16,093
| +63% | +$385K | ﹤0.01% | 656 |
|
|
2023
Q1 | $479K | Buy |
+25,444
| New | +$479K | ﹤0.01% | 863 |
|
|
2021
Q2 | – | Sell |
-16,458
| Closed | -$425K | – | 1519 |
|
|
2021
Q1 | $425K | Sell |
16,458
-24,580
| -60% | -$635K | ﹤0.01% | 1286 |
|
|
2020
Q4 | $2.19M | Sell |
41,038
-5,025
| -11% | -$269K | 0.01% | 626 |
|
|
2020
Q3 | $1.9M | Sell |
46,063
-31,641
| -41% | -$1.31M | 0.01% | 586 |
|
|
2020
Q2 | $3.77M | Buy |
77,704
+12,374
| +19% | +$600K | 0.02% | 458 |
|
|
2020
Q1 | $2.76M | Buy |
65,330
+20,297
| +45% | +$857K | 0.02% | 461 |
|
|
2019
Q4 | $1.93M | Buy |
45,033
+3,574
| +9% | +$153K | 0.01% | 652 |
|
|
2019
Q3 | $1.49M | Buy |
41,459
+25,739
| +164% | +$926K | 0.01% | 706 |
|
|
2019
Q2 | $420K | Sell |
15,720
-17,325
| -52% | -$463K | ﹤0.01% | 1096 |
|
|
2019
Q1 | $887K | Buy |
+33,045
| New | +$887K | ﹤0.01% | 893 |
|
|
2018
Q3 | – | Sell |
-450,345
| Closed | -$6.88M | – | 1378 |
|
|
2018
Q2 | $6.88M | Buy |
+450,345
| New | +$6.88M | 0.04% | 427 |
|
|
2015
Q2 | – | Sell |
-12,775
| Closed | -$416K | – | 1200 |
|
|
2015
Q1 | $416K | Buy |
+12,775
| New | +$416K | ﹤0.01% | 974 |
|